Real-time reverse transcriptase polymerase chain reaction (RT rtPCR) was used to quantify the pattern of inflammatory mediator mRNA expression in circulating leukocytes from adult patients diagnosed with severe sepsis. We analysed 29 blood samples from 26 severely septic patients with different septic sources and eight samples from eight healthy adult volunteers. RT rtPCR was used to quantify mRNA expression of 21 different inflammatory mediators in peripheral leukocytes. The median variability in gene expression in the sepsis patients was 10.5 times greater than the variability of the healthy comparison group. We found a significant change in the regulation for the following genes: C5aR (20-fold, P<0.001), P<0.001), MMP9 (72-fold, P<0.001), HSP70 (2.4-fold, P=0.02), and RIP2 (1.8-fold, P<0.04) were up-regulated. Conversely the median expression of IFNγ, and IL-6 were zero (P<0.001), and mtHSP (0.4-fold, P=0.02) was significantly down-regulated. Using linear discriminant analysis, IFNγ, IL-12, and TLR4 were correlated to a negative outcome. Different septic sources (peritonitis, burn, pneumonia and musculo-skeletal infections) resulted in significantly different mRNA patterns. The RT rtPCR is a useful tool to monitor the immune response in septic patients. We found a very high variability in inflammatory mediator expression among septic patients compared to healthy volunteers. This suggests that any future immunemodulatory therapy may need to be individualized to the patient's requirements as monitored by RT rtPCR. Different sources of sepsis may result in markedly different activation patterns.
Severe sepsis, complicated by multi-organ failure, is a major cause of death in the intensive care unit (ICU) patients, with mortality rates around 30 to 45%. A complex network of control elements regulates the human immune response. The systemic appearance of diverse biological mediators plays a central role in the pathophysiology of sepsis and inflammation, including microbial signal molecules, inflammatory mediators, complement activation and cell adhesion molecules. Of special interest is the expression of different inflammatory mediators, which exert pleiotropic effects on cells of the immune system and transduce signals via specific surface receptors. Inflammatory mediators are expressed in cascades by different cells such as neutrophils, macrophages, and epithelial and mesenchymal cells. These peptides play a pivotal part in initiating and regulating the innate immune response. They function in networks, in which feedback at many points occurs to control further cellular responses and to regulate the inflammatory response. To understand the system, measurement of many mediators simultaneously is required. To our knowledge this has not been done previously.
There are a variety of ways to measure inflammatory mediator activity. Most studies measure the amount of circulating mediators in the blood, using specific antibodies and quantification by ELISA or flow-cytometry 1, 2 . Plasma levels are difficult to interpret because they measure only the inflammatory mediator overflow into the blood, effectively the endocrine component of inflammatory mediator effect. The local inflammatory mediator effects, autocrine and paracrine receptor binding, are undetected; therefore the plasma levels potentially underestimate the effective amount of mediators acting at cellular levels and give limited insight into the activation of the leukocytes and the innate immune system 3, 4 . We chose to use real-time reverse transcriptase polymerase chain reaction (RT rtPCR) as the most practical way of quantifying simultaneously, multiple inflammatory mediator gene expression in circulating leukocytes.
Precise knowledge of the state of the immune response is crucial to guide immunomodulatory therapy in septic patients. Early in the course of sepsis, the immune system is thought to be in a hyperinflammatory state. As determined by various, largely unknown factors (virulence, size of innoculum, patient condition, age and genetic polymorphisms), the patient subsequently usually moves to a hypoinflammatory state 5, 6 . At present the clinical assessment of the activity of the immune system is crude. Clinicians rely on indirect methods (such as leukocyte counts, Th1/Th2 ratios, or HLA-DR expression) to measure the activity of the immune system. This inability to estimate the spectrum of innate immune system activation makes it impossible to intelligently target immunomodulatory or immunostimulatory therapies 7 . For example, in an individual patient, do we need to give steroids to dampen their immune response, or drugs like interferon gamma to increase it 8 ? Other recent trials of immunomodulatory therapies have failed to achieve positive results. One of the reasons for the failure is because individual septic patients may display their own unique inflammatory mediator responses to the septic insult. Moreover, it has been reported that innate immune genes have extensive genetic polymorphisms that influence immunological response to bacterial infection 9 .
In this study, our aim was to show that the RT rtPCR technique could be a useful tool to investigate the expression of inflammatory markers from peripheral leukocytes in patients with septic shock. We further hypothesized that every patient has a unique response to inflammation and that different diseases activate the immune system in a specific way.
MATERIALS AND METHODS

Patient Selection
The study was approved by the Waikato Ethics Committee and informed consent was obtained from the volunteers and from the patients (or their next of kin). Intensive care patients who presented with a clinical diagnosis of a severe septic episode were recruited. The criteria for a diagnosis of sepsis were similar to those of the PROWESS trial (i.e. a source of infection with associated organ dysfunction and systemic inflammation). We analysed 29 blood samples taken from 26 patients. Subsequently we classified the severity of the disease according to the sepsis-related (later called "sequential") organ failure assessment (SOFA) score. We took blood samples as early as possible in the septic episode. In four patients the sample was taken with a delay of over 24 hours because they were inter-hospital transfers to our tertiary intensive care unit. The patients' characteristics and clinical data are shown in Table 1 . Good outcome was defined as survival to ICU discharge. In addition, blood samples from eight healthy volunteers were taken to serve as comparisons (5 male, 3 female, age 28-48 years). The patients' treatment consisted of surgical control of the septic source, antibiotics and organ support. The patients were classified into four disease groups according to the source of their infection: peritonitis, burns, pneumonia and other (musculo-skeletal) infections.
Laboratory Methods
After a literature search, we chose 21 representative genes from a variety of different groups of inflammatory mediators: two housekeeper genes (β actin and β2 microglobulin), toll-like receptors 2 and 4 (TLR2, TLR4), interleukins 1, 6, 8, and 12 (IL1β, IL-6, IL-8, IL12) transcription factors (nuclear factor kappa B, NFκB), cellular receptors (CD14, CD11, triggering receptor expressed on myeloid cells (TREM)), heat shock proteins 70 and mitochondrial (HSP70, mtHSP), complement factor 5a receptor (C5aR) growth factors (platelet-derived growth factor, PDGF) and others (matrix metalloproteinase 9 MMP9, myeloperoxidase MPO, interferon gamma IFNγ, interleukin 1 receptor associated kinase IRAKM, receptor interacting protein 2 RIP2). These genes were chosen because they were thought to be important in the pathology of sepsis and would give an insight into the interactions between the different inflammatory mediators. Table 2 shows the abbreviation, major activity and the source of expression of the investigated mRNA transcripts. One ml of blood was taken from the arterial catheter and, because some inflammatory mediator mRNA is labile, we processed the samples within 90 minutes of collection in the molecular genetic laboratory of the University of Waikato. For this period of time the changes in mRNA expression have been shown to be minimal 10 . We did duplicate RT rtPCR runs on a subset of the mRNA samples. The mean (SD) difference in cycle threshold (CT) values between the two runs was -0.06 (1.09). The details of the laboratory methods and gene quantification are available on our website (http://www.anaes-icu-waikato.org.nz). The quantification is expressed as the -fold change in inflammatory mediator expression, compared to the normal healthy comparison subjects (see statistical analysis). The β2 microglobulin gene was used as the housekeeping gene. This is required because the absolute amounts of total mRNA will vary between different samples. If the sample is large, there will be more housekeeping gene. We then quantify the amount of expression for each gene relative to that of the housekeeping gene.
Statistical Analysis
We used the Systat (v10, SPSS Inc, Chicago, IL) statistical package for statistical analysis. relative to that found in the normal comparison group 11 . A 2 -∆∆ CT value of 10 for a particular gene implies a tenfold increase in inflammatory mediator transcription. For the purposes of statistical analysis and graphical display, the 2 -∆∆ CT values were transformed to a Gaussian distribution (by raising the values to the power of 0.2, K-S test for normality), and then a one-sample t-test used to detect if the 2 -∆∆ CT was significantly different from one. A ratio of one implies equal expression compared with the healthy comparisons. The differences in expression between the four disease groups were compared using one-way ANOVA. We used Fisher's Least Significant Difference as a post hoc test to discriminate differences between individual disease groups. We tested for association between continuous variables using Pearson's linear correlation coefficient (r). A forward stepwise linear discriminant function was developed, to discover which multivariate combination of inflammatory mediators may be associated with patient outcome. We used a P value of 0.1 for inclusion and removal of each prospective inflammatory mediator parameter in the multivariate model. To compare the variability of gene expression, we used the ratio of the inter-quartile range (IQR) between the septic patients and the comparison group, (termed "variability ratio"). We obtained the 2 -∆ CT value for each gene and sample. If the IQR of the 2 -∆ CT values of the samples for a certain gene in the septic group was the same as the IQR of the samples obtained from the comparison group, the variability ratio was one.
RESULTS
Variability of Gene Expression
The most obvious result of our study was that septic patients showed great variation in expression of inflammatory mediators. This may be interpreted as the primary manifestation of sepsis-induced disturbance in normal inflammatory mediator homeostasis. The tight control of mediator expression, which was found in the healthy comparison group, was lost in the septic group. Taking all the inflammatory mediators together, the median variability ratio was 10.5. Those genes that were markedly dysregulated as evidenced by a variability ratio >10 were: [CD11=41.5, C5aR= 31.4, MMP9=259.5, IL-8=20.6, HSP70=14.7, and IRAKM=10.2]. Those moderately different from normal (variability ratio=1 to 10) were: [PDGF=8.7, NFκB=2.8, mtHSP=0.9, TLR2=5.0, TLR4=2.3, CD14=6.1, TREM=0.8, IL -12=5.15, RIP2=3.7]. There was a small group in which the variability was markedly less than normal comparisons: [IFNγ=0, IL-1β=0.1, MPO=0.6, IL-6=0.0037]. Those genes that were up-regulated showed most variation (variability ratio vs median expression, r=0.75).
Overall Changes in Mediator Expression
When comparing the gene expression of the whole group of septic patients with the gene expression in the volunteers, there was a significant (median -fold, P value) up-regulation of: C5aR (20-fold, P<0.001), IL-8 (29-fold, P<0.001), MMP9 (72-fold, P<0.001), HSP70 (2.4-fold, P=0.02), and RIP2 (1.8-fold, P<0.04). Conversely the median expression of IFNγ, and IL-6 were zero (P<0.001), and mtHSP (0.4-fold, P=0.02) was significantly down-regulated ( Figure 1 ).
Correlation with Clinical Outcome
Individually, none of the mediators correlated strongly with outcome. IL-8 was moderately correlated to the SOFA Score (r=0.41, P=0.06). The multivariate analysis found that expression of IFNγ, IL-12, and TLR4 were important in the prediction of outcome. In this very small sample set, the linear discriminant function (using the jacknife correction) resulted in a 79% correct prediction of outcome. The mRNA expression of the inflammatory mediators did not correlate significantly with any white blood cell subgroup counts (neutrophils, monocytes, lymphocytes, eosinophils or basophils). Inclusion of total leukocyte count or each of the subgroup counts as forced co-variates did not significantly influence the multivariate model.
Changes in Specific Patient Groups
Although the numbers were small, different diseases (peritonitis (n=6), burn (n=4), pneumonia (n=6) and other infections(n=10)) resulted in differences in inflammatory mediator mRNA expression patterns. NFκB (P=0.01), RIP2 (P=0.04), and MMP9 (P=0.04) differed between the four patient groups (examples in Figure 2 ). On post hoc testing, mRNA expression in patients with burns was significantly greater than in the pneumonia patients for: IFNγ (P=0.04), PDGF (0.02), NFκB (P=0.01), IRAKM (P=0.04), and RIP2 (P=0.02). MMP9 (P=0.01) was more strongly expressed in the patients with abdominal sepsis as compared with pneumonia or other sepsis patients. IL -8 (P=0.01) was significantly decreased in the pneumonia group as compared with the other sepsis patients.
DISCUSSION
Inflammatory mediator expression has been extensively investigated in a variety of different diseases, in different organs, at various levels, and with different methods 4, [12] [13] [14] [15] . To our knowledge, the gene transcription of such a wide variety of mediators in septic patients has not been compared to volunteers using the RT rtPCR technique. Most previous studies measured inflammatory mediator peptide levels in peripheral blood [16] [17] [18] [19] . These levels measure only the tip of the inflammatory mediator iceberg. They do not detect inflammatory mediators that are bound to their receptors, those cleared by their inhibitors, and those with very low levels. It is difficult to correlate the level of mRNA expression with the functional activity of the end-protein for a variety of reasons. For example, some mRNAs will be transcribed and translated but remain inactive because of their requirement for post-translational modifications-e.g. they may need to be phosphorylated to become active.
Although it is very sensitive and specific, RT rtPCR needs accurate optimization to achieve reliable results. Avoiding co-amplification of genomic DNA, inter-assay variability, and normalization to a relevant housekeeper gene need to be taken into account 20, 21 . Normalization to a housekeeping gene to compare the level of gene expression can be difficult, as a housekeeper gene is needed whose expression is not influenced by the patient's disease. We chose the β2 microglobulin gene as it had previously been shown to be more reliable than glyceraldehyde-3-phosphate dehydrogenase (GADPH), 18 s ribosomal RNA, (actin and porphobilinogen deaminase (PBDG) for leukocytes 22, 23 caused over-or under-expression of the housekeeper gene, we would have expected to see all the study genes to be consistently reciprocally under-or overexpressed. This was not the pattern that we found, giving us confidence that our results were not biased by systematic changes in housekeeper gene expression. The major limitation with the use of RT rtPCR is that mRNA expression may not always correlate with protein functionality, which itself may be unmeasurable at present.
This study demonstrates that the RT rtPCR technique has the potential to be used to investigate the expression of different inflammatory markers. With the appropriate clinical laboratory set-up, potentially the results of a blood sample could be available after about eight hours. Our results clearly demonstrate a markedly enhanced (tenfold greater) variability in inflammatory mediator expression in the septic patient group as compared with healthy volunteers. Whereas the IQR values of inflammatory mediator expression in the comparison group are relatively narrow, the IQR values for the septic group fluctuate in expression more extensively in all the genes except those that were downregulated (IFNγ, IL-6, mtHSP). Whether this variation is a reflection of individual genetic variability or the result of a hyperactive immune state, or a combination of both, is unknown. However this enhanced variability is a clear indication of dysregulation of the normal homeostatic control mechanisms of innate immunity. Using a microarray technique, Whitney and co-workers found a similar increased variation of gene expression in septic patients compared with healthy people 24 .
Of the nineteen inflammatory markers examined, five (MMP9, C5aR, IL-8, HSP70, RIP2) were found to be upregulated in our patients, and three (IFNγ, IL-6 and mtHSP) showed diminished expression. MMP9 is stored in the granules of neutrophils. After release it degrades the endothelial membranes with induction of a vascular leakage and oedema formation. MMP9 had the highest expression in our study. Yassen found high plasma levels of this inflammatory marker in septic patients, while Nakamura and coworkers found a high MMP9 plasma level as well as high mRNA expression (using Northern blot analysis) in monocytes of twenty septic shock patients 25, 26 . They also reported a negative correlation between outcome and MMP9 expression. C5aR and IL-8 were the next most up-regulated, both have been reported to be expressed on the surface of human blood neutrophils 27 . C5a is a 74 amino acid peptide cleaved from the complement protein C5 and represents the most potent anaphylatoxin, possessing inflammatory and immune-modulatory activity 28 . In other studies, peripheral blood levels of IL-8 were found to be increased in septic patients and correlated inversely to outcome 16, 18, 19 . Together, with MMP9, all the upregulated genes are involved in the signalling network of peripheral mononuclear cells. HSP70 has also been reported to be up-regulated in human blood leukocytes 1 . The inflammatory mediator RIP2, which is involved in the NOD-induced signalling cascades, is induced by TLRs and leads to NFκB activation through TNFα. It has only been investigated in vitro as yet. It also differentiates Th1 cells (but not Th2 cells) and induces both adaptive and innate immunity in the host 29, 30 . In our study RIP2 was significantly upregulated and had, unlike other genes, a very small variation in its expression in septic patients. In contrast, IFNγ was barely expressed in our septic patients, using RT rtPCR (the most sensitive method of detecting gene expression). We speculate that administration of IFNγ may be a useful therapy. Doecke and co-workers treated nine septic patients who had a low HLA-DR expression with IFNγ and could show in vivo and in vitro, a restoration of monocytic activation. Eight patients (much more than estimated), survived from sepsis 8 . Similarly Rigato et al 31 found impaired expression of IFNγ in phytohemagglutinin-activated blood of septic patients. The lack of IFNγ indicates the suppression of the lymphocytic Th1 immune responses that has been related to increased mortality in other studies. There is evidence accumulating that the dominant problem in sepsis is the down-regulation of the immune system in the later stages 32 and that most deaths occur in the hypoimmune state 6 . Although we processed the blood samples within 90 minutes, it is possible that our very low IFNγ and IL-6 mRNA expression could be caused by extreme lability of the mRNA for each of these genes. The issue of mRNA degradation is controversial, but we could find no published evidence that the mRNA could have been degraded within 90 minutes. Studies by Duvigneau et al and Rainen et al found an increased expression of IFNγ mRNA with time (>4 hours). This is in contrast to Stordeur et al who found that mRNA for IFNγ degrades slowly with time 10, 33, 34 .
This study gives only a single snapshot of the patient's inflammatory profile relatively early in their illness. At present we have little information as to how the profile varies with progression in time 35 . When we stratified septic patients into subgroups according to their diagnosis (peritonitis, burns, pneumonia, other sepsis), large differences in the inflammatory mediator expression pattern were observed compared with that of the overall group. Patients who were septic as a result of burns had greater expression of IFNγ, PDGF, NFκB, IRAKM, and RIP2 compared with pneumonia patients. The variability in the pattern of inflammatory mediator expression between septic sources has not been described in previous literature to our knowledge, although inflammatory mediators are known to be expressed differently in different organs 3, 36 . It would indicate that the common practice in the literature of lumping into one group, septic patients who are suffering from a wide range of differing illnesses is likely to obscure real treatment effects.
We may speculate that our observations may have clinical implications. To get a positive outcome in any immune response modulating therapy, it may be necessary to target the treatment to the needs of the individual patient. For example CD14 overall was not, on average, up-or down-regulated compared with healthy comparisons. However in some patients, principally our pneumonia patients, it was barely expressed at all. De Werra et al, using different measuring techniques, found a similar wide variation in levels of CD14 protein in septic patients, but not in patients with pneumonia or cardiogenic shock 2 . It is easy to imagine that CD14 blockade might be harmful in those patients with down-regulated CD14, as Tasaka et al found in a murine study 32 . It will be interesting to see the results of an ongoing multicentre study treating community acquired pneumonia patients with CD14 inhibitor. There seems to be little rationale in blocking some peptides that are already downregulated, or to block inflammatory mediators (such as IL-6 37 or CD14 38 ) that are easily bypassed via redundant pathways. It may make more sense to modulate hubs like NFκB or RIP2 39 .
The correlation of gene expression with clinical state, leukocyte counts and differentials was generally poor. This is, in part, the result of the small numbers of patients studied. However it may indicate that mRNA expression is probably contributing fresh information that is unobtainable from the routine clinical assessment or leukocyte counts. Larger, longitudinal studies are underway to evaluate the usefulness of the transcription information in prognosis and treatment of sepsis 19, 40 .
We were able to show that the RT rtPCR is a useful technique to quantify mRNA expression and it is straightforward to target new genes of interest from the growing list of inflammatory mediators. We found that every septic patient has his own unique immune response, shown by the high variability in inflammatory mediator mRNA expression in these patients compared to healthy volunteers. We also found that different diseases resulted in different activation patterns. Because of this large variability, future immunomodulatory therapy may need to be individualized to each patient's inflammatory mediator expression pattern.
